DJIA 18,068.71 15.00 0.08%
NASDAQ 4,808.94 2.08 0.04%
S&P 500 2,092.79 4.02 0.19%
market minute promo

Gilead Sciences (NASDAQ: GILD)

97.00 3.21 (3.42%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $97.01 3.43%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $96.07
Previous Close $93.79
Daily Range $95.40 - $97.31
52-Week Range $63.50 - $116.83
Market Cap $146.3B
P/E Ratio 16.63
Dividend (Yield) $0.00 (0.0%)
Volume 8,159,091
Average Daily Volume 19,233,453
Current FY EPS $7.91

Sector

Healthcare

Industry

Drugs

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

Is Gilead Sciences, Inc. a Value Stock Following Its Tumble?

Gilead Sciences' slate of catalysts and a forward P/E of less than 10 make it intriguing.

Is Gilead Already Coming Back Into Favor?

Gilead Sciences (GILD) Stock Rises Following Janssen Agreement Expansion

Morning Market Movers

Health Care Sector Update for 12/29/2014: POZN, AEZS, GILD

Top Analyst Upgrades and Downgrades: Ambarella, Gilead, MarkWest, PNC, Skyworks, RigNet, Sonus and M

Top Analyst Upgrades and Downgrades: Ambarella, Gilead, MarkWest, PNC, Skyworks, RigNet, Sonus and More

Pre-Market Most Active for Dec 29, 2014 : RIO, TVIX, ALU, FCAU, GILD, XIV, JUNO, AAPL, PBR, BAC, GP

Pre-Market Most Active for Dec 29, 2014 : RIO, TVIX, ALU, FCAU, GILD, XIV, JUNO, AAPL, PBR, BAC, GPRO, MTW

Benzinga's Top Upgrades

Analysts' Actions: Ambarella, Gilead, Halyard Health and More

Biotech Weekly: Charts And Themes Present Mildly Bullish Outlook Into 2015

My 2015 Growth Stock Picks

See More GILD News...

GILD's Top Competitors

GILD $97.00 (3.42%)
Current stock: GILD
AMGN $162.39 (-0.65%)
Current stock: AMGN
CELG $113.60 (0.22%)
Current stock: CELG
$0.00 (0.00%)
Current stock: